And 800 cases lined up against Monsanto….
Blood-thinning drug Xarelto faces 18,000 lawsuits
by Jon Rappoport
April 26, 2017
The first court test of Bayer/J&J’s billion-dollar bonanza, blood-thinner, Xarelto, is coming up in New Orleans next week. The outcome will influence how the 18,000 lawsuits behind it will be handled.
The plaintiff in the first suit is Joseph Boudreaux. “While Xarelto was supposed to help cut his stroke risk, Boudreaux says it instead caused internal bleeding that required a week-long hospital stay in the intensive-care unit, several blood transfusions and multiple heart procedures. ‘I don’t want anybody else to suffer like I have from that drug,’ the part-time security guard says,” reports the Chicago Tribune.
Lawyers for Bayer and J&J will argue, in the main, that Xarelto was approved by the FDA as safe and effective.
This is the normal front-line strategy in cases where the drugmaker believes it can’t be accused of purposely concealing a…
View original post 513 more words